Details for New Drug Application (NDA): 071376
✉ Email this page to a colleague
The generic ingredient in HALOPERIDOL is haloperidol decanoate. There are twenty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
Summary for 071376
Tradename: | HALOPERIDOL |
Applicant: | Watson Labs |
Ingredient: | haloperidol |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 071376
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Jun 3, 1988 | TE: | RLD: | No |
Complete Access Available with Subscription